A purpose-built commercial organization for surgeon-developed medical device IP. From patent to operating room to strategic exit — without the surgeon ever having to become a business operator.
LoxaNova is a self-contained domestic commercial organization built specifically for surgeon IP. We take a product from patent to operating room to acquisition-ready — and the surgeon retains ownership through every stage.
IP audit, maintenance management, 510(k) pathway mapping, and manufacturing sourcing. We handle the infrastructure that turns a patent into a market-ready product.
Proof-of-concept deployment in a controlled Texas market. Trained field educators in the OR. Every case documented. Every procedure tied to a patent family. Clean utilization data that supports a premium valuation.
Individual IP brokerage or full company acquisition. We bring the utilization data, the commercial track record, and the competitive tension that creates real negotiating leverage with strategic buyers.
Every arthroscopic procedure uses a cannula. Dr. Worrel's Suremka portfolio owns a meaningful piece of that space — surgical access and instrumentation technology developed over a decade of high-volume clinical practice at the Carrell Clinic and in the NBA. The portfolio is clean. No existing licenses. No encumbrances. Ready to move.
| Patent | Description | Year | Status |
|---|---|---|---|
| 8,777,902 | Retractable Cannula — Generation 1 | 2014 | Issued |
| 10,258,368 | Retractable Cannula — Generation 2 | 2019 | Issued |
| EP15806528.4 | Retractable Cannula — UK, France, Germany | 2020 | European |
| 10,342,577 | Surgical Devices and Methods | 2019 | Issued |
| 10,687,846 | Surgical Devices and Methods — Divisional | 2020 | Issued |
| 11,607,246 | Surgical Device Deployment Apparatuses | 2023 | Issued |
| 11,607,322 | Graft Compression System | 2023 | Issued |
| 12,427,039 | Graft Compression System — CIP | 2025 | Issued |
| 11,627,985 | Surgical Devices & Deployment Apparatuses | 2023 | Issued |
| 18/355,936 | Surgical Devices & Deployment Apparatuses | Pending | Pending |
| 18/336,287 | Knotless Suture Shuttling & Anchoring System | Pending | Pending |
| 18/295,414 | Surgical Devices & Deployment Apparatuses | Pending | Pending |
| 19/252,607 | Surgical Devices & Deployment Apparatuses — Newest | 2025 | Pending |
The goal is simple. Daniel focuses on patients. LoxaNova runs the commercial organization, builds the data record, and creates the conditions for a premium exit. The surgeon entrepreneur finally has a partner who knows how to execute.
You don't manage reps, chase purchase orders, or sit in VAT committee meetings. LoxaNova handles the entire commercial layer. Your time stays in the OR.
Every case documented. Every procedure tied to your IP. When a strategic buyer asks for proof of market adoption, we hand them a clean report instead of a pitch deck.
A proven commercial track record changes the acquisition conversation. You stop being a seller with an idea and become a seller with a business. That distinction is worth multiples.
This is the first chapter. LoxaNova becomes the platform other surgeon entrepreneurs use to bring their IP to market. Your success builds something that helps the entire community of surgical innovators.
No term sheets today. No legal discussions. Just three people who have built real things in this industry sitting down to talk about whether this is worth doing together. We believe it is.